Favipiravir Bioanalysis [Regulatives / Guidelines]

posted by Ayman Rabayah – Jordan, 2020-08-11 08:44 (255 d 04:54 ago) – Posting: # 21854
Views: 950

Hellow colleagues
Need your feedback about the Bio-analysis of Favipiravir, do the metabolite (Favipiravir RTP) need to be measured or only the Favipiravir, since no FDA or EMEA related guidance issued till date.
Appreciate your thoughts.

Ayman Ahmad

Complete thread:

 Admin contact
21,429 posts in 4,479 threads, 1,512 registered users;
online 27 (0 registered, 27 guests [including 4 identified bots]).
Forum time: Friday 13:39 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz